Atlas Trials

Acute Myeloid Leukemia Refractory

28 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Acute Myeloid Leukemia Refractory

RecordFirmDate
Treatment With ABT-199 (Venetoclax) and Purine Analogues in Relapsed/Refractory Acute Myeloid Leukemia (NCT05506332)University Hospital, Antwerp2022-07-15
AB8939 in Patients With Relapsed/Refractory Acute Myeloid Leukemia (NCT05211570)AB Science2022-06-01
Administration of Anti-siglec-6 CAR-T Cell Therapy in Relapsed and Refractory Acute Myeloid Leukemia (rr/AML) (NCT05488132)Xuzhou Medical University2022-04-01
PLAT-08: A Study Of SC-DARIC33 CAR T Cells In Pediatric And Young Adults With Relapsed Or Refractory CD33+ AML (NCT05105152)Seattle Children's Hospital2021-11-29
KPT-9274 in Patients With Relapsed and Refractory Acute Myeloid Leukemia (NCT04914845)University of Colorado, Denver2021-08-27
CD123 Redirected T Cells for AML in Pediatric Subjects (NCT04678336)University of Pennsylvania2021-04-02
Natural Killer-cell Therapy for Acute Myeloid Leukemia (NCT04347616)Radboud University Medical Center2020-12-03
Lentivirally Redirected CD123 Autologous T Cells in AML (NCT03766126)University of Pennsylvania2018-12-06
A Phase 1 Study to Evaluate FN-1501 Monotherapy in Patients With Advanced Solid Tumors and R/R AML (NCT03690154)Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd.2018-07-23

Track Acute Myeloid Leukemia Refractory automatically

Every clearance here is in the API, with alerts when new ones post.